TrialClinical and translational science2017

Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction.

N Plock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.